Repetitive Transcranial Magnetic Stimulation in Treatment and Prophylaxis of Chronic Migraine in Patients With no Prophylactic Treatment for the Last 3 Months

Chronic Migraine Clinical Trial

— rTMS  

Official title:

Repetitive Transcranial Magnetic Stimulation in Treatment of Chronic Migraine

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06461767
• Other study ID #: Soh-Med-24-05-06MS
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2024
• Est. completion date: January 1, 2025

Study information

• Verified date: June 2024
• Source: Sohag University
• Contact: Tarek Mohamed
• Phone: 01025545002
• Email: tarikmohamed[@]med.sohag.edu.eg
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Compared with the patients with episodic migraine those with chronic migraine have worst quality of life and more severe headache related disability we investigate Repetitive transcranial magnetic stimulation in treatment and prophylaxis of chronic migraine

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: January 1, 2025
• Est. primary completion date: January 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion criteria:

• A study sample of patients with chronic migraine according to international classification of headache disorders-3 (ICHD-3).

• Patients are regular on follow up visits.

Exclusion criteria:

• Patients with depression by Hamiliton scale of depression by using its Arabic version Translated by Dr Lotfy Fateem

• patients on prophylactic medications for chronic migraine.

• pregnancy.

• cochlear implants, cardiac pacemaker, and metal body implanted in head-and-neck region.

• Patients refused to give informed consent.

• History of seizures.

Related Conditions & MeSH terms

• Chronic Migraine
• Migraine Disorders

Intervention

Device:
• transcranial magnetic stimulation device
Repetitive transcranial magnetic stimulation parameters: stimulation site: left dorsolateral prefrontal cortex and left motor cortex intensity: 70% of resting motor threshold frequency: 15 Hz number of pulses: 30

Locations

Country	Name	City	State
Egypt	Sohag faculty of medicine	Sohag

Sponsors (1)

Lead Sponsor	Collaborator
Sohag University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	improvement of headache severity and number of attacks of headache before and after intervention by visual analogue scale and headache impact test	improvement of headache severity and number of attacks of headache before and after intervention by visual analogue scale and headache impact test	one month after treatment